Skip to content

Clinical trials

Schizophrenia trials in Canada with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Unknown status Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20082
20141
20153
20163
20192
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health3
St. Joseph's Healthcare Hamilton2
University of British Columbia2
University of Ottawa2
Ciusss de L'Est de l'Île de Montréal1
Corporation de Recherche en Neuropsycho Pharmacologie de Quebec1
Hamilton Health Sciences Corporation1
Lady Davis Institute1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Otsuka Canada Pharmaceutical Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia17
Psychotic Disorders9
Hallucinations2
Anxiety Disorders1
Bipolar Disorder1
Diabetes Mellitus1
Schizophrenia, Treatment-Resistant1
Weight Gain1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.